288 related articles for article (PubMed ID: 37223527)
1. Oncolytic viruses: A novel treatment strategy for breast cancer.
Javanbakht M; Tahmasebzadeh S; Cegolon L; Gholami N; Kashaki M; Nikoueinejad H; Mozafari M; Mozaffari M; Zhao S; Khafaei M; Izadi M; Fathi S; Akhavan-Sigari R
Genes Dis; 2023 Mar; 10(2):430-446. PubMed ID: 37223527
[TBL] [Abstract][Full Text] [Related]
2. Promising oncolytic agents for metastatic breast cancer treatment.
Cody JJ; Hurst DR
Oncolytic Virother; 2015; 4():63-73. PubMed ID: 27512671
[TBL] [Abstract][Full Text] [Related]
3. Systemic virotherapy for multiple myeloma.
Oliva S; Gambella M; Boccadoro M; Bringhen S
Expert Opin Biol Ther; 2017 Nov; 17(11):1375-1387. PubMed ID: 28796556
[TBL] [Abstract][Full Text] [Related]
4. Advances in viral oncolytics for treatment of multiple myeloma - a focused review.
Sarwar A; Hashim L; Faisal MS; Haider MZ; Ahmed Z; Ahmed TF; Shahzad M; Ansar I; Ali S; Aslam MM; Anwer F
Expert Rev Hematol; 2021 Dec; 14(12):1071-1083. PubMed ID: 34428997
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response.
Wu YY; Sun TK; Chen MS; Munir M; Liu HJ
Front Cell Infect Microbiol; 2023; 13():1142172. PubMed ID: 37009515
[TBL] [Abstract][Full Text] [Related]
6. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of oncolytic virus therapy against cancer.
Russell L; Peng KW
Chin Clin Oncol; 2018 Apr; 7(2):16. PubMed ID: 29764161
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.
Guo ZS; Thorne SH; Bartlett DL
Biochim Biophys Acta; 2008 Apr; 1785(2):217-31. PubMed ID: 18328829
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic viruses: how "lytic" must they be for therapeutic efficacy?
Davola ME; Mossman KL
Oncoimmunology; 2019; 8(6):e1581528. PubMed ID: 31069150
[TBL] [Abstract][Full Text] [Related]
10. Targeting pediatric cancer stem cells with oncolytic virotherapy.
Friedman GK; Cassady KA; Beierle EA; Markert JM; Gillespie GY
Pediatr Res; 2012 Apr; 71(4 Pt 2):500-10. PubMed ID: 22430386
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical.
Tang C; Li L; Mo T; Na J; Qian Z; Fan D; Sun X; Yao M; Pan L; Huang Y; Zhong L
Clin Transl Oncol; 2022 Sep; 24(9):1682-1701. PubMed ID: 35612653
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic Viruses for Multiple Myeloma Therapy.
Calton CM; Kelly KR; Anwer F; Carew JS; Nawrocki ST
Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29903988
[TBL] [Abstract][Full Text] [Related]
13. Reovirus - possible therapy of cancer.
Figova K; Hrabeta J; Eckschlager T
Neoplasma; 2006; 53(6):457-62. PubMed ID: 17167712
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic vaccinia virus: from bedside to benchtop and back.
Thorne SH
Curr Opin Mol Ther; 2008 Aug; 10(4):387-92. PubMed ID: 18683104
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic viruses: From bench to bedside with a focus on safety.
Buijs PR; Verhagen JH; van Eijck CH; van den Hoogen BG
Hum Vaccin Immunother; 2015; 11(7):1573-84. PubMed ID: 25996182
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic virus therapy for prostate cancer.
Fukuhara H; Homma Y; Todo T
Int J Urol; 2010 Jan; 17(1):20-30. PubMed ID: 19832925
[TBL] [Abstract][Full Text] [Related]
17. Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.
Seegers SL; Frasier C; Greene S; Nesmelova IV; Grdzelishvili VZ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694943
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic Virotherapy for Cancer: Clinical Experience.
Chaurasiya S; Fong Y; Warner SG
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33924556
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potency of oncolytic virotherapy in breast cancer targeting, current status and perspective.
Ebrahimi S; Ghorbani E; Shafiee M; Ryzhikov M; Hassanian SM; Azadmanesh K
J Cell Biochem; 2019 Mar; 120(3):2801-2809. PubMed ID: 30260014
[TBL] [Abstract][Full Text] [Related]
20. RNA viruses as virotherapy agents.
Russell SJ
Cancer Gene Ther; 2002 Dec; 9(12):961-6. PubMed ID: 12522435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]